These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25322271)

  • 1. A novel missense mutation in the HSD3B2 gene, underlying nonsalt-wasting congenital adrenal hyperplasia. new insight into the structure-function relationships of 3β-hydroxysteroid dehidrogenase type II.
    Baquedano MS; Ciaccio M; Marino R; Perez Garrido N; Ramirez P; Maceiras M; Turjanski A; Defelipe LA; Rivarola MA; Belgorosky A
    J Clin Endocrinol Metab; 2015 Jan; 100(1):E191-6. PubMed ID: 25322271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revisiting Classical 3β-hydroxysteroid Dehydrogenase 2 Deficiency: Lessons from 31 Pediatric Cases.
    Guran T; Kara C; Yildiz M; Bitkin EC; Haklar G; Lin JC; Keskin M; Barnard L; Anik A; Catli G; Guven A; Kirel B; Tutunculer F; Onal H; Turan S; Akcay T; Atay Z; Yilmaz GC; Mamadova J; Akbarzade A; Sirikci O; Storbeck KH; Baris T; Chung BC; Bereket A
    J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31950145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refining hormonal diagnosis of type II 3beta-hydroxysteroid dehydrogenase deficiency in patients with premature pubarche and hirsutism based on HSD3B2 genotyping.
    Mermejo LM; Elias LL; Marui S; Moreira AC; Mendonca BB; de Castro M
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1287-93. PubMed ID: 15585552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two novel HSD3B2 missense mutations with diverse residual enzymatic activities for Δ5-steroids.
    Takasawa K; Ono M; Hijikata A; Matsubara Y; Katsumata N; Takagi M; Morio T; Ohara O; Kashimada K; Mizutani S
    Clin Endocrinol (Oxf); 2014 Jun; 80(6):782-9. PubMed ID: 24372086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insight into the molecular basis of 3beta-hydroxysteroid dehydrogenase deficiency: identification of eight mutations in the HSD3B2 gene eleven patients from seven new families and comparison of the functional properties of twenty-five mutant enzymes.
    Moisan AM; Ricketts ML; Tardy V; Desrochers M; Mébarki F; Chaussain JL; Cabrol S; Raux-Demay MC; Forest MG; Sippell WG; Peter M; Morel Y; Simard J
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4410-25. PubMed ID: 10599696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel A10E homozygous mutation in the HSD3B2 gene causing severe salt-wasting 3beta-hydroxysteroid dehydrogenase deficiency in 46,XX and 46,XY French-Canadians: evaluation of gonadal function after puberty.
    Alos N; Moisan AM; Ward L; Desrochers M; Legault L; Leboeuf G; Van Vliet G; Simard J
    J Clin Endocrinol Metab; 2000 May; 85(5):1968-74. PubMed ID: 10843183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of two novel homozygous missense mutations involving codon 6 and 259 of type II 3beta-hydroxysteroid dehydrogenase (3betaHSD) gene causing, respectively, nonsalt-wasting and salt-wasting 3betaHSD deficiency disorder.
    Zhang L; Mason JI; Naiki Y; Copeland KC; Castro-Magana M; Gordon-Walker TT; Chang YT; Pang S
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1678-85. PubMed ID: 10770215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel nonstop mutation in the stop codon and a novel missense mutation in the type II 3beta-hydroxysteroid dehydrogenase (3beta-HSD) gene causing, respectively, nonclassic and classic 3beta-HSD deficiency congenital adrenal hyperplasia.
    Pang S; Wang W; Rich B; David R; Chang YT; Carbunaru G; Myers SE; Howie AF; Smillie KJ; Mason JI
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2556-63. PubMed ID: 12050213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel homozygous Q334X mutation in the HSD3B2 gene causing classic 3β-hydroxysteroid dehydrogenase deficiency: an unexpected diagnosis after a positive newborn screen for 21-hydroxylase deficiency.
    Jeandron DD; Sahakitrungruang T
    Horm Res Paediatr; 2012; 77(5):334-8. PubMed ID: 22343390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A novel homozygous mutation p.E25X in the HSD3B2 gene causing salt wasting 3β-hydroxysteroid dehydrogenases deficiency in a Chinese pubertal girl: a delayed diagnosis until recurrent ovary cysts].
    Huang Y; Zheng J; Xie T; Xiao Q; Lu S; Li X; Cheng J; Chen L; Liu L
    Zhonghua Er Ke Za Zhi; 2014 Dec; 52(12):948-51. PubMed ID: 25619355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital adrenal hyperplasia due to 3beta-hydroxysteroid dehydrogenase/Delta(5)-Delta(4) isomerase deficiency.
    Simard J; Moisan AM; Morel Y
    Semin Reprod Med; 2002 Aug; 20(3):255-76. PubMed ID: 12428206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico structural, functional and pathogenicity evaluation of a novel mutation: an overview of HSD3B2 gene mutations.
    Rabbani B; Mahdieh N; Haghi Ashtiani MT; Setoodeh A; Rabbani A
    Gene; 2012 Jul; 503(2):215-21. PubMed ID: 22579964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A New Homozygous Frameshift Mutation in the HSD3B2 Gene in an Apparently Nonconsanguineous Italian Family.
    Bizzarri C; Massimi A; Federici L; Cualbu A; Loche S; Bellincampi L; Bernardini S; Cappa M; Porzio O
    Horm Res Paediatr; 2016; 86(1):53-61. PubMed ID: 27082427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carboxyl-terminal mutations in 3beta-hydroxysteroid dehydrogenase type II cause severe salt-wasting congenital adrenal hyperplasia.
    Welzel M; Wüstemann N; Simic-Schleicher G; Dörr HG; Schulze E; Shaikh G; Clayton P; Grötzinger J; Holterhus PM; Riepe FG
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1418-25. PubMed ID: 18252794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural aspects of the p.P222Q homozygous mutation of HSD3B2 gene in a patient with congenital adrenal hyperplasia.
    Lusa LG; Lemos-Marini SH; Soardi FC; Ferraz LF; Guerra-Júnior G; Mello MP
    Arq Bras Endocrinol Metabol; 2010 Nov; 54(8):768-74. PubMed ID: 21340167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of 3β-hydroxysteroid dehydrogenase activity using progesterone and androgen receptors-mediated transactivation.
    Yazawa T; Watanabe Y; Yokohama Y; Imamichi Y; Hasegawa K; Nakajima KI; Kitano T; Ida T; Sato T; Islam MS; Umezawa A; Takahashi S; Kato Y; Jahan S; Kawabe JI
    Front Endocrinol (Lausanne); 2024; 15():1480722. PubMed ID: 39415787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analyzing the functional and structural consequences of two point mutations (P94L and A368D) in the CYP11B1 gene causing congenital adrenal hyperplasia resulting from 11-hydroxylase deficiency.
    Krone N; Grischuk Y; Müller M; Volk RE; Grötzinger J; Holterhus PM; Sippell WG; Riepe FG
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2682-8. PubMed ID: 16670167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-Virilizing Congenital Adrenal Hyperplasia in a Female Patient with a Novel HSD3B2 Mutation.
    Probst-Scheidegger U; Udhane SS; l'Allemand D; Flück CE; Camats N
    Sex Dev; 2016; 10(4):200-204. PubMed ID: 27626911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and functional characterization of the novel missense mutation Y254D in type II 3 beta-hydroxysteroid dehydrogenase (3 beta HSD) gene of a female patient with nonsalt-losing 3 beta HSD deficiency.
    Sanchez R; Rhéaume E; Laflamme N; Rosenfield RL; Labrie F; Simard J
    J Clin Endocrinol Metab; 1994 Mar; 78(3):561-7. PubMed ID: 8126127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis of congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency.
    Simard J; Rhéaume E; Sanchez R; Laflamme N; de Launoit Y; Luu-The V; van Seters AP; Gordon RD; Bettendorf M; Heinrich U
    Mol Endocrinol; 1993 May; 7(5):716-28. PubMed ID: 8316254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.